IMO E. Only A and E are contender.
which of the following practices, if adopted by a pharmaceutical company, would hinder its long-term success.
A: Incentivising the sale of any particular group of medicines over any other group of medicines for the medical representatives--> Companies want to increase the sale of particular group of medicine over other "possibly more popular or profitable" and hence they will give more incentives.
E:Monitoring the success or failure of the medical
...
which of the following practices, if adopted by a pharmaceutical company, would hinder its long-term success.
A: Incentivising the sale of any particular group of medicines over any other group of medicines for the medical representatives--> Companies want to increase the sale of particular group of medicine over other "possibly more popular or profitable" and hence they will give more incentives.
E:Monitoring the success or failure of the medical
...





